Inventor · disambiguated record
Kelly Loyet
Also filed as: LOYET KELLY · LOYET KELLY M · LOYET KELLY MICHELE
6 granted patents·11 pending applications·44 citations·filing 2004–2024
82Inventor score
Top patents by PatentIndex Score
17 records- 0191US10421822B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 24, 2019·4 cites·52 claims
- 0291US7479544B2Anti-PRO87299 antibodiesGENENTECH INC·Filed 2004·Granted Jan 20, 2009·33 cites·18 claims
- 0386US2024067752A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2023·Application pending·0 cites
- 0485US10421821B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 24, 2019·2 cites·44 claims
- 0583US11512143B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2019·Granted Nov 29, 2022·1 cites·21 claims
- 0683US7863422B2Anti-PRO87299 antibodiesGENENTECH INC·Filed 2008·Granted Jan 4, 2011·4 cites·12 claims
- 0782US2023383008A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2022·Application pending·0 cites
- 0872US2025002609A1Anti-klk5 antibodies and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0966US2009081229A1Anti-pro87299 antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 1066US2023416825A1Use of klk5 antagonists for the treatment of a diseaseGENENTECH INC·Filed 2023·Application pending·0 cites
- 1163US12037412B2Anti-KLK5 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Jul 16, 2024·0 cites·13 claims
- 1260US2024327522A1Anti-alpha v beta 8 integrin antibodies and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 1359US2025002575A1Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1458US2012171208A1Anti-PRO87299 AntibodiesCLARK HILARY·Filed 2012·Application pending·0 cites
- 1554US2020040103A1Anti-klk5 antibodies and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 1645US2009175855A1Novel compositions and methods for the treatment of immune related diseasesCLARK HILARY·Filed 2007·Application pending·0 cites
- 1742US2019078160A1Use of klk5 antagonists for treatment of a diseaseGENENTECH INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →